Canadian guideline on genetic screening for hereditary renal cell cancers

Authors

  • M. Neil Reaume Division of Medical Oncology, The Ottawa Hospital Cancer Centre and the University of Ottawa, Ottawa, Ontario
  • Gail E. Graham Eastern Ontario Regional Genetics Program, Children's Hospital of Eastern Ontario and the University of Ottawa, Ottawa, Ontario
  • Eva Tomiak Eastern Ontario Regional Genetics Program, Children's Hospital of Eastern Ontario and the University of Ottawa, Ottawa, Ontario
  • Suzanne Kamel-Reid Molecular Diagnostics, Department of Pathology, The University Health Network, University of Toronto ,Toronto, Ontario
  • Michael A.S. Jewett Division of Urology, Departments of Surgical Oncology and Surgery, Princess Margaret Cancer Centre and the University Health Network, University of Toronto, Toronto, Ontario
  • Georg A Bjarnason Division of Medical Oncology/Hematology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario
  • Normand Blais Division of Hematology/Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec
  • Melanie Care Fred A. Litwin Family Centre in Genetic Medicine, University Health Network & Mount Sinai Hospital, Toronto, Ontario
  • Darryl Drachenberg Section of Urology, Department of Surgery, 
University of Manitoba, Winnipeg, Manitoba
  • Craig Gedye Ontario Cancer Institute, Princess Margaret Cancer Centre and the University Health Network, Toronto, Ontario
  • Ronald Grant Division of Haematology/Oncology, Department of Paediatrics, University of Toronto, Toronto, Ontario
  • Daniel Y.C. Heng Department of Medical Oncology, Tom Baker Cancer Center, and the University of Calgary, Calgary, Alberta
  • Anil Kapoor McMaster Institute of Urology, Division of Urology, Department of Surgery, McMaster University, Hamilton, Ontario
  • Christian Kollmannsberger Division of Medical Oncology, British Columbia Cancer Agency-Vancouver Cancer Centre, and the Univeristy of British Columbia, Vancouver, British Columbia
  • Jean-Baptiste Lattouf Department of Surgery, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec
  • Eamonn R. Maher Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge
  • Arnim Pause Department of Biochemistry, McGill University, Montreal, Quebec
  • Dean Ruether Department of Medical Oncology, Tom Baker Cancer Center, and the University of Calgary, Calgary, Alberta
  • Denis Soulieres Division of Hematology/Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec
  • Simon Tanguay Division of Urology, McGill University, Montreal, Quebec
  • Sandra Turcotte Department of Chemistry and Biochemistry, Universite de Moncton, Moncton, New Brunswick
  • Philippe D. Violette Division of Urology, Department of Surgery, Western University, London, Ontario
  • Lori Wood Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia
  • Joan Basiuk Kidney Cancer Research Network of Canada, Toronto, Ontario
  • Stephen E. Pautler Division of Urology, Department of Surgery and Division of Surgical Oncology, Department of Oncology, Western University, London, Ontario

DOI:

https://doi.org/10.5489/cuaj.1496

Keywords:

Hereditary Renal Cancer Associated 1, Carcinoma, Renal Cell, screening, genetic testing,

Abstract

Background: Hereditary renal cell cancer (RCC) is an ideal model for germline genetic testing. We propose a guideline of hereditary RCC specific criteria to suggest referral for genetic assessment.

Methods: A review of the literature and stakeholder resources for existing guidelines or consensus statements was performed. Referral criteria were developed by expert consensus.

Results: The criteria included characteristics for patients with RCC (age ≤45 years, bilateral or multifocal tumours, associated medical conditions and non-clear cell histologies with unusual features) and for patients with or without RCC, but a family history of specific clinical or genetic diagnoses.

Conclusions: This guideline represents a practical RCC-specific reference to allow healthcare providers to identify patients who may have a hereditary RCC syndrome, without extensive knowledge of each syndrome. RCC survivors and their families can also use the document to guide their discussions with healthcare providers about their need for referral. The criteria refer to the most common hereditary renal tumour syndromes and do not represent a comprehensive or exclusive list. Prospective validation of the criteria is warranted.

Downloads

Download data is not yet available.

Downloads

Published

2013-10-09

How to Cite

Reaume, M. N., Graham, G. E., Tomiak, E., Kamel-Reid, S., Jewett, M. A., Bjarnason, G. A., Blais, N., Care, M., Drachenberg, D., Gedye, C., Grant, R., Heng, D. Y., Kapoor, A., Kollmannsberger, C., Lattouf, J.-B., Maher, E. R., Pause, A., Ruether, D., Soulieres, D., Tanguay, S., Turcotte, S., Violette, P. D., Wood, L., Basiuk, J., & Pautler, S. E. (2013). Canadian guideline on genetic screening for hereditary renal cell cancers. Canadian Urological Association Journal, 7(9-10), 319–23. https://doi.org/10.5489/cuaj.1496

Issue

Vol. 7 No. 9-10 (2013): CUAJ October

Section

Clinical Practice Guideline

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.